Feud Arises Over Planned Sale of Sika to Saint-Gobain

A feud has sprung up in Switzerland over the planned sale of a controlling stake in family-controlled building chemicals producer Sika to French conglomerate Saint-Gobain for about $2.8 billion.

One of the world's largest manufacturers of specialty chemicals for the for the construction industry, including adhesives and sealants used in waterproofing and soundproofing, Sika employs more than 16,000 people in 84 countries and posted revenue of 5.14 billion Swiss francs in 2013.

Schenker-Winkler Holding, owned by the Burkard family - which also controls the Swiss chemical firm despite having only a minority shareholding - has called for an extraordinary general meeting to remove three board directors opposing the sale, including chairman Paul J. Hälg and board members Monika Ribar and Daniel J. Sauter, chairman of Swiss private bank Julius Baer Group.

The family, which already has three directors on Sika's board, wants to replace the three with nominees of its own. Schenker-Winkler holds 16.1% of Sika's capital, but has 52.4% of the voting rights, despite the fact that nearly 84% of the company founded in 1910 by Kaspar Winkler is in public ownership.

Sika's three oppositionalist directors have said they will resign, along with management, if the deal goes through. They contend that selling the stake to an industrial conglomerate could have negative consequences for the company's public shareholders. Saint-Gobain could incorporate Sika without buying any of the other 85.9% of shares.

A successful sale would be a "disaster for the public shareholders, among them pension funds," one analyst told the news agency Reuters.

Saint-Gobain, Europe's largest supplier of building materials with €42 billion in revenue in 2013 and 190,000 employees in 64 countries, said it hoped the deal would generate €100 million in annual cost savings from 2017.

The French group has said it does not intend to make an offer for the remaining shares of the Swiss company.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.